WQ
BIB icon

Wealth Quarterback’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Wealth Quarterback’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5K Hold
44
– – ﹤0.01% 585
2021
Q2 		$5K Buy
+44
New +$3.84K ﹤0.01% 603

Other funds holding BIB

HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

Wealth Quarterback's BIB Position: Q3 2021 in Review

Wealth Quarterback held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q3 2021 at 44 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Wealth Quarterback first reported a position in BIB in Q2 2021 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold BIB as of Q3 2021.

  • Wealth Quarterback held 44 shares of ProShares Ultra NASDAQ Biotechnology worth $5K as of Q3 2021.
  • Wealth Quarterback left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q3 2021.
  • ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #585 holding.
  • Wealth Quarterback first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2021 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.